Scholars Central

Conference abstractPublished 28 Jul 2016

In vitro and in vivo evaluation of novel folate-targeted polymer lipid hybrid nanoparticles for paclitaxel delivery

Authors: Dunwan Zhu, Linhua Zhang, Zhuo Chen

Chinese Academy of Medical Sciences & Peking Union Medical College, China

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

To reduce the toxicity and improve the therapeutic efficacy paclitaxel (PTX), folate-targeted polymer-lipid hybrid nanoparticles were prepared and evaluated for the delivery of PTX. The purpose of this study was to develop a novel lipid-polymer hybrid drug carrier comprised of folate (FA) modified lipid-shell and polymer-core nanoparticles (FLPNPs) for sustained, controlled and targeted delivery of PTX. PTX-FLPNPs were synthesized that composed of folate (as targeting ligand), DSPE-PEG2000 (as lipidshell) and PCL-PEG-PCL (as self-assembled core) using thin-film hydration and ultrasonic dispersion method. The nanoparticles were evaluated in vitro and in vivo to assure the sustainable, controlled and targeted delivery of PTX. The PTX-loaded FLPNPs were successfully prepared with apparent lipid monolayer shell. High drug loading of more than 26% (w/w) could be achieved with high encapsulation efficiency of more than 90% when the PTX feed ratio was 30% (w/w). PTX was released in a controlled and sustained fashion with no apparent initial drug burst. Cellular uptake proved the internalization efficiency and targeting ability of the folate conjugation. In EMT-6 breast tumor model, intra-tumoral administration of PTX-loaded FLPNPs showed similar antitumor efficacy but low toxicity compared to TaxolÃ?®. More importantly, PTX-loaded FLPNPs showed greater tumor growth inhibition (65.78%) than the non-targeted PTX-loaded LPNPs (48.38%; p<0.05). PTX loaded-FLPNPs with mixed lipid monolayer shell and biodegradable polymer core would be a promising Nano sized drug formulation for tumor targeted therapy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalImmunotherapy: Open Access
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Dunwan Zhu”
  • BylineArticles whose byline prints “Linhua Zhang”
  • BylineArticles whose byline prints “Zhuo Chen”